Alison E. Fohner

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2C9</i> and <i>HLA‐B</i> Genotypes and Phenytoin Dosing: 2020 Update

Jason H. Karnes, Allan E. Rettie, Andrew A. Somogyi et al. · Clinical Pharmacology & Therapeutics · 2020 · 163 citations · Full text

Toxic Epidermal Necrolysis, Therapeutic Drug Monitoring, Translational Pharmacology +15

Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research

Rachel Huddart, Alison E. Fohner, Michelle Whirl‐Carrillo et al. · Clinical Pharmacology & Therapeutics · 2018 · 133 citations · Full text

PharmGKB summary

Alison E. Fohner, Alex Sparreboom, Russ B. Altman et al. · Pharmacogenetics and Genomics · 2017 · 77 citations · Full text

Alison E., Literary History, Humanities +6

Interindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase content

Yoshiyuki Shirasaka, Amarjit S. Chaudhry, Matthew G. McDonald et al. · The Pharmacogenomics Journal · 2015 · 70 citations · Full text

Assessing clinical heterogeneity in sepsis through treatment patterns and machine learning

Alison E. Fohner, J Greene, Brian L. Lawson et al. · Journal of the American Medical Informatics Association · 2019 · 69 citations · Full text